Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
4.670
-0.050 (-1.06%)
Nov 17, 2026, 3:04 PM CST

SHE:002252 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
6,1937,3408,1747,9626,5664,285
Other Revenue
8.438.432.851.571.323.01
6,2017,3488,1767,9646,5674,288
Revenue Growth
-22.03%-10.13%2.67%21.27%53.16%55.26%
Cost of Revenue
4,0094,6584,8724,7353,6782,069
Gross Profit
2,1922,6903,3043,2292,8892,219
Selling, General & Admin
845.98803.9867.79712.75706.48616.64
Research & Development
281.38223.37250.9173.74145.71129.02
Other Operating Expenses
55.0346.5448.6631.4932.8123.05
Operating Expenses
1,1691,0941,211912.68900.18756.75
Operating Income
1,0231,5962,0932,3161,9891,462
Interest Expense
-81.43-44.11-0.22-0.12-0.26-0.47
Interest & Investment Income
431.37422.59634.16135.38510.69466.09
Currency Exchange Gain (Loss)
16.7916.79-85.01-43.34-56.5511.28
Other Non Operating Income (Expenses)
13.96-11.27-0.08-0.42-1.42-1.91
EBT Excluding Unusual Items
1,4031,9802,6422,4082,4411,937
Impairment of Goodwill
-94.02-94.02---197.02-361.19
Gain (Loss) on Sale of Investments
-0.78---196.8918.38-42.76
Gain (Loss) on Sale of Assets
23.621.16-1.61-0.010.23-1.35
Asset Writedown
24.990.07-13.23-4.31-2.47-9.26
Other Unusual Items
-6.17-1.73-7.07-2.5213.1116.54
Pretax Income
1,3511,9062,6202,2042,2741,539
Income Tax Expense
265.83328.93426.31426.65400.61250.09
Earnings From Continuing Operations
1,0851,5772,1941,7771,8731,289
Minority Interest in Earnings
-0.42-0.52.047.095.56
Net Income
1,0851,5772,1931,7791,8801,295
Net Income to Common
1,0851,5772,1931,7791,8801,295
Net Income Growth
-40.58%-28.10%23.25%-5.35%45.24%-2.21%
Shares Outstanding (Basic)
6,5706,5786,6176,5916,7416,741
Shares Outstanding (Diluted)
6,5756,5836,6176,5916,7416,741
Shares Change
-0.52%-0.51%0.39%-2.23%-5.28%
EPS (Basic)
0.170.240.330.270.280.19
EPS (Diluted)
0.170.240.330.270.280.19
EPS Growth
-39.90%-27.35%22.22%-3.19%46.80%-8.09%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,317-713.52-889.21,8271,5001,089
Free Cash Flow Per Share
-0.20-0.11-0.130.280.220.16
Dividend Per Share
0.0330.0480.0700.0300.0300.028
Dividend Growth
-31.68%-31.00%133.33%0%7.14%12.00%
Gross Margin
35.35%36.61%40.41%40.54%43.99%51.75%
Operating Margin
16.49%21.72%25.60%29.09%30.29%34.10%
Profit Margin
17.50%21.46%26.82%22.34%28.63%30.19%
Free Cash Flow Margin
-21.23%-9.71%-10.88%22.94%22.84%25.41%
EBITDA
1,2571,8182,2992,4772,1691,616
EBITDA Margin
20.26%24.74%28.11%31.10%33.03%37.69%
D&A For EBITDA
233.86221.71205.52160.39180.33154.07
EBIT
1,0231,5962,0932,3161,9891,462
EBIT Margin
16.49%21.72%25.60%29.09%30.29%34.10%
Effective Tax Rate
19.68%17.26%16.27%19.36%17.62%16.25%
Revenue as Reported
---7,9646,5674,288
Advertising Expenses
-108.83193.47143.4193.23169.52